

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.84890167 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.81250312 |
| 3 | synaptic vesicle maturation (GO:0016188) | 4.79794178 |
| 4 | locomotory exploration behavior (GO:0035641) | 4.74567226 |
| 5 | glutamate secretion (GO:0014047) | 4.30085192 |
| 6 | vocalization behavior (GO:0071625) | 4.26263200 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.25522681 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.24393246 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 4.22097850 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.16510766 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.13753259 |
| 12 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.89458926 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.89086838 |
| 14 | protein localization to synapse (GO:0035418) | 3.85283153 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.79614047 |
| 16 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.79139974 |
| 17 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.70278768 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.69376100 |
| 19 | neurotransmitter secretion (GO:0007269) | 3.67128781 |
| 20 | cerebellar granule cell differentiation (GO:0021707) | 3.66656265 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.65234425 |
| 22 | exploration behavior (GO:0035640) | 3.57744574 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.56711604 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.56711604 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 3.53297862 |
| 26 | gamma-aminobutyric acid transport (GO:0015812) | 3.49785590 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 3.42515817 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 3.40398164 |
| 29 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.37370888 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 3.36325865 |
| 31 | long-term memory (GO:0007616) | 3.33013257 |
| 32 | postsynaptic membrane organization (GO:0001941) | 3.27765972 |
| 33 | amino acid import (GO:0043090) | 3.24942373 |
| 34 | neuron-neuron synaptic transmission (GO:0007270) | 3.23701054 |
| 35 | neuronal action potential propagation (GO:0019227) | 3.22708900 |
| 36 | cellular potassium ion homeostasis (GO:0030007) | 3.22681587 |
| 37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.21701257 |
| 38 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.16239254 |
| 39 | positive regulation of membrane potential (GO:0045838) | 3.06723480 |
| 40 | regulation of postsynaptic membrane potential (GO:0060078) | 3.03656685 |
| 41 | regulation of synaptic plasticity (GO:0048167) | 3.02537884 |
| 42 | layer formation in cerebral cortex (GO:0021819) | 3.01662116 |
| 43 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.00796258 |
| 44 | membrane depolarization during action potential (GO:0086010) | 2.99385259 |
| 45 | neuronal ion channel clustering (GO:0045161) | 2.98370260 |
| 46 | proline transport (GO:0015824) | 2.98279064 |
| 47 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.97721507 |
| 48 | L-phenylalanine catabolic process (GO:0006559) | 2.97721507 |
| 49 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.96530456 |
| 50 | urea metabolic process (GO:0019627) | 2.96015277 |
| 51 | urea cycle (GO:0000050) | 2.96015277 |
| 52 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.95748101 |
| 53 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.94357021 |
| 54 | positive regulation of Rap GTPase activity (GO:0032854) | 2.93305135 |
| 55 | regulation of ARF protein signal transduction (GO:0032012) | 2.92605139 |
| 56 | cell differentiation in hindbrain (GO:0021533) | 2.92165762 |
| 57 | regulation of neurotransmitter transport (GO:0051588) | 2.92108672 |
| 58 | neurotransmitter transport (GO:0006836) | 2.91685741 |
| 59 | long-term synaptic potentiation (GO:0060291) | 2.90456056 |
| 60 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.90274092 |
| 61 | synaptic vesicle endocytosis (GO:0048488) | 2.89965022 |
| 62 | behavioral response to cocaine (GO:0048148) | 2.87487227 |
| 63 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.87454153 |
| 64 | sodium ion export (GO:0071436) | 2.86934395 |
| 65 | dendritic spine morphogenesis (GO:0060997) | 2.86405303 |
| 66 | aromatic amino acid family catabolic process (GO:0009074) | 2.85488980 |
| 67 | regulation of synapse maturation (GO:0090128) | 2.84436471 |
| 68 | high-density lipoprotein particle remodeling (GO:0034375) | 2.84377576 |
| 69 | regulation of female receptivity (GO:0045924) | 2.82486312 |
| 70 | regulation of neurotransmitter levels (GO:0001505) | 2.82462369 |
| 71 | neuron cell-cell adhesion (GO:0007158) | 2.82376253 |
| 72 | glutamate metabolic process (GO:0006536) | 2.81629655 |
| 73 | potassium ion import (GO:0010107) | 2.81218093 |
| 74 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.80529439 |
| 75 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.78352900 |
| 76 | L-amino acid import (GO:0043092) | 2.77963940 |
| 77 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.77401491 |
| 78 | neuromuscular process controlling balance (GO:0050885) | 2.76789264 |
| 79 | neuromuscular process controlling posture (GO:0050884) | 2.76661042 |
| 80 | L-phenylalanine metabolic process (GO:0006558) | 2.75148572 |
| 81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.75148572 |
| 82 | kynurenine metabolic process (GO:0070189) | 2.74294864 |
| 83 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.74004958 |
| 84 | auditory behavior (GO:0031223) | 2.74000397 |
| 85 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.73621300 |
| 86 | response to histamine (GO:0034776) | 2.73326785 |
| 87 | membrane depolarization (GO:0051899) | 2.72741832 |
| 88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.71405258 |
| 89 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.70535717 |
| 90 | regulation of Rap GTPase activity (GO:0032317) | 2.70516138 |
| 91 | regulation of vesicle fusion (GO:0031338) | 2.70428369 |
| 92 | tryptophan catabolic process (GO:0006569) | 2.69484093 |
| 93 | indole-containing compound catabolic process (GO:0042436) | 2.69484093 |
| 94 | indolalkylamine catabolic process (GO:0046218) | 2.69484093 |
| 95 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.68866843 |
| 96 | positive regulation of neurotransmitter transport (GO:0051590) | 2.68226062 |
| 97 | regulation of exocytosis (GO:0017157) | 2.68195758 |
| 98 | positive regulation of synapse maturation (GO:0090129) | 2.67096496 |
| 99 | bile acid biosynthetic process (GO:0006699) | 2.66000265 |
| 100 | positive regulation of dendritic spine development (GO:0060999) | 2.64644252 |
| 101 | central nervous system myelination (GO:0022010) | 2.63854658 |
| 102 | axon ensheathment in central nervous system (GO:0032291) | 2.63854658 |
| 103 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.63454991 |
| 104 | activation of protein kinase A activity (GO:0034199) | 2.62607201 |
| 105 | nitrogen cycle metabolic process (GO:0071941) | 2.61600400 |
| 106 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.61214744 |
| 107 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.60374473 |
| 108 | behavioral defense response (GO:0002209) | 2.59812725 |
| 109 | behavioral fear response (GO:0001662) | 2.59812725 |
| 110 | cell migration in hindbrain (GO:0021535) | 2.59752128 |
| 111 | regulation of beta-amyloid formation (GO:1902003) | 2.59051579 |
| 112 | prepulse inhibition (GO:0060134) | 2.58702127 |
| 113 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.58405497 |
| 114 | regulation of dendritic spine development (GO:0060998) | 2.56283740 |
| 115 | glycine transport (GO:0015816) | 2.55311232 |
| 116 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.55245748 |
| 117 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.54738622 |
| 118 | reverse cholesterol transport (GO:0043691) | 2.54561767 |
| 119 | regulation of neurotransmitter secretion (GO:0046928) | 2.53820311 |
| 120 | alanine transport (GO:0032328) | 2.52923547 |
| 121 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.52400822 |
| 122 | neuromuscular synaptic transmission (GO:0007274) | 2.52257669 |
| 123 | positive regulation of mast cell activation (GO:0033005) | 2.51785804 |
| 124 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.50740863 |
| 125 | female mating behavior (GO:0060180) | 2.50000130 |
| 126 | synaptic transmission (GO:0007268) | 2.49467423 |
| 127 | response to auditory stimulus (GO:0010996) | 2.48931453 |
| 128 | transmission of nerve impulse (GO:0019226) | 2.47446791 |
| 129 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.47375096 |
| 130 | phospholipid efflux (GO:0033700) | 2.47130683 |
| 131 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.46698338 |
| 132 | alpha-linolenic acid metabolic process (GO:0036109) | 2.46244685 |
| 133 | complement activation, alternative pathway (GO:0006957) | 2.46181383 |
| 134 | chemosensory behavior (GO:0007635) | 2.44557439 |
| 135 | presynaptic membrane organization (GO:0097090) | 2.44393516 |
| 136 | positive regulation of synaptic transmission (GO:0050806) | 2.44219082 |
| 137 | vesicle transport along microtubule (GO:0047496) | 2.44135883 |
| 138 | regulation of synaptic transmission (GO:0050804) | 2.43540738 |
| 139 | negative regulation of dendrite development (GO:2000171) | 2.43214365 |
| 140 | tryptophan metabolic process (GO:0006568) | 2.42375046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.12240051 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.95249047 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.72948796 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.41256469 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.40488307 |
| 6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.36357382 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.26340917 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.21467673 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.19615468 |
| 10 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.06192151 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06097795 |
| 12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.05548782 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02509650 |
| 14 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.96636196 |
| 15 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.96636196 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.91579177 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.90916572 |
| 18 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.86700976 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.84727078 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81849494 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.75935628 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.75632203 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.72905885 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72330534 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.67635812 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.60881270 |
| 27 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58567788 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.57740899 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.56459877 |
| 30 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.56394980 |
| 31 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.56040477 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54736141 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.51148005 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49665489 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.48178192 |
| 36 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47976236 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43847331 |
| 38 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.40985990 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34540594 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.32617205 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32122724 |
| 42 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31111825 |
| 43 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30855962 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30668664 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30211152 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28031228 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.22625889 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22414728 |
| 49 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21442599 |
| 50 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19991867 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19889185 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17634962 |
| 53 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17385064 |
| 54 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17209094 |
| 55 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17114518 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.15538577 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.15381692 |
| 58 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.15124814 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14415961 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12052341 |
| 61 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11144519 |
| 62 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.11077246 |
| 63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10825937 |
| 64 | AR_19668381_ChIP-Seq_PC3_Human | 1.10008863 |
| 65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09108513 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08756588 |
| 67 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07745878 |
| 68 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07745878 |
| 69 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.07699096 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07386024 |
| 71 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06731110 |
| 72 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06711239 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05830202 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05606131 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05194364 |
| 76 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05184497 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04302109 |
| 78 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03282525 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03013644 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.02867789 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02019148 |
| 82 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.01398659 |
| 83 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.01201166 |
| 84 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00980191 |
| 85 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00494316 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00127402 |
| 87 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99973190 |
| 88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99916789 |
| 89 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99852773 |
| 90 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.99656201 |
| 91 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99502997 |
| 92 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97911067 |
| 93 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97030930 |
| 94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96338314 |
| 95 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96012846 |
| 96 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96009783 |
| 97 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95977880 |
| 98 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.94970615 |
| 99 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94817640 |
| 100 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.94372273 |
| 101 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93095489 |
| 102 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92633789 |
| 103 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.92490688 |
| 104 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91454554 |
| 105 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91319649 |
| 106 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.90056118 |
| 107 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89806392 |
| 108 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89519661 |
| 109 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.88421817 |
| 110 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.88128264 |
| 111 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86654707 |
| 112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86553587 |
| 113 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.86417981 |
| 114 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86303723 |
| 115 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84593860 |
| 116 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83357368 |
| 117 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.83288170 |
| 118 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.83169799 |
| 119 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.82861424 |
| 120 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.82018227 |
| 121 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81739895 |
| 122 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81453123 |
| 123 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.81223423 |
| 124 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80649186 |
| 125 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80649186 |
| 126 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.80251775 |
| 127 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.80130972 |
| 128 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80111087 |
| 129 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79794423 |
| 130 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79639636 |
| 131 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.78730634 |
| 132 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.78495135 |
| 133 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.75045104 |
| 134 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.74822461 |
| 135 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74460766 |
| 136 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73880860 |
| 137 | KDM2B_26808549_Chip-Seq_REH_Human | 0.73269901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.17921737 |
| 2 | MP0003880_abnormal_central_pattern | 3.94225595 |
| 3 | MP0005360_urolithiasis | 3.59132614 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.53038489 |
| 5 | MP0002822_catalepsy | 3.49572630 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.48028695 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.25166148 |
| 8 | MP0004270_analgesia | 3.09310877 |
| 9 | MP0009745_abnormal_behavioral_response | 2.96177017 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.90215179 |
| 11 | MP0005365_abnormal_bile_salt | 2.77670302 |
| 12 | MP0002064_seizures | 2.74657255 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.46526890 |
| 14 | MP0009046_muscle_twitch | 2.38516300 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.37127249 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.33912188 |
| 17 | MP0001486_abnormal_startle_reflex | 2.13352642 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.08338704 |
| 19 | MP0002272_abnormal_nervous_system | 1.98825183 |
| 20 | MP0010329_abnormal_lipoprotein_level | 1.91190975 |
| 21 | MP0003329_amyloid_beta_deposits | 1.89037448 |
| 22 | MP0003252_abnormal_bile_duct | 1.88322077 |
| 23 | MP0002734_abnormal_mechanical_nocicepti | 1.81408365 |
| 24 | MP0005423_abnormal_somatic_nervous | 1.81346275 |
| 25 | MP0003724_increased_susceptibility_to | 1.75133846 |
| 26 | MP0002736_abnormal_nociception_after | 1.74669543 |
| 27 | MP0003075_altered_response_to | 1.67431317 |
| 28 | MP0002735_abnormal_chemical_nociception | 1.66653723 |
| 29 | MP0000604_amyloidosis | 1.66177768 |
| 30 | MP0001440_abnormal_grooming_behavior | 1.65952622 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.60855034 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 1.60838952 |
| 33 | MP0003183_abnormal_peptide_metabolism | 1.59249061 |
| 34 | MP0001348_abnormal_lacrimal_gland | 1.51692880 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.48207308 |
| 36 | MP0003690_abnormal_glial_cell | 1.48032664 |
| 37 | MP0003879_abnormal_hair_cell | 1.46779057 |
| 38 | MP0003633_abnormal_nervous_system | 1.45942692 |
| 39 | MP0008569_lethality_at_weaning | 1.45519453 |
| 40 | MP0002067_abnormal_sensory_capabilities | 1.39901155 |
| 41 | MP0002090_abnormal_vision | 1.39804670 |
| 42 | MP0003436_decreased_susceptibility_to | 1.38503742 |
| 43 | MP0008874_decreased_physiological_sensi | 1.37795011 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.36841936 |
| 45 | MP0001666_abnormal_nutrient_absorption | 1.36802077 |
| 46 | MP0002733_abnormal_thermal_nociception | 1.35893504 |
| 47 | MP0001970_abnormal_pain_threshold | 1.35648280 |
| 48 | MP0004924_abnormal_behavior | 1.34419086 |
| 49 | MP0005386_behavior/neurological_phenoty | 1.34419086 |
| 50 | MP0004858_abnormal_nervous_system | 1.29923895 |
| 51 | MP0004811_abnormal_neuron_physiology | 1.29800820 |
| 52 | MP0004742_abnormal_vestibular_system | 1.28514199 |
| 53 | MP0004147_increased_porphyrin_level | 1.26870802 |
| 54 | MP0008872_abnormal_physiological_respon | 1.24999509 |
| 55 | MP0005671_abnormal_response_to | 1.24244958 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.23893400 |
| 57 | MP0005535_abnormal_body_temperature | 1.22967615 |
| 58 | MP0003011_delayed_dark_adaptation | 1.22940432 |
| 59 | MP0005083_abnormal_biliary_tract | 1.20912858 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.20278407 |
| 61 | MP0001835_abnormal_antigen_presentation | 1.19107393 |
| 62 | MP0004510_myositis | 1.18749797 |
| 63 | MP0009840_abnormal_foam_cell | 1.14909257 |
| 64 | MP0000569_abnormal_digit_pigmentation | 1.14403265 |
| 65 | MP0001800_abnormal_humoral_immune | 1.13624369 |
| 66 | MP0001986_abnormal_taste_sensitivity | 1.11877229 |
| 67 | MP0010234_abnormal_vibrissa_follicle | 1.11484787 |
| 68 | MP0001984_abnormal_olfaction | 1.11204150 |
| 69 | MP0001502_abnormal_circadian_rhythm | 1.10719929 |
| 70 | MP0003631_nervous_system_phenotype | 1.10345621 |
| 71 | MP0005166_decreased_susceptibility_to | 1.09598493 |
| 72 | MP0003172_abnormal_lysosome_physiology | 1.08933242 |
| 73 | MP0002118_abnormal_lipid_homeostasis | 1.07103046 |
| 74 | MP0005332_abnormal_amino_acid | 1.06859692 |
| 75 | MP0004885_abnormal_endolymph | 1.06787918 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.06125530 |
| 77 | MP0003045_fibrosis | 1.04828626 |
| 78 | MP0005387_immune_system_phenotype | 1.03683200 |
| 79 | MP0001790_abnormal_immune_system | 1.03683200 |
| 80 | MP0004019_abnormal_vitamin_homeostasis | 1.03668164 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.03341669 |
| 82 | MP0003868_abnormal_feces_composition | 1.02990940 |
| 83 | MP0005000_abnormal_immune_tolerance | 1.02081042 |
| 84 | MP0002066_abnormal_motor_capabilities/c | 1.01456409 |
| 85 | MP0002653_abnormal_ependyma_morphology | 1.01160249 |
| 86 | MP0003303_peritoneal_inflammation | 1.00788274 |
| 87 | MP0002229_neurodegeneration | 0.99546829 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99495014 |
| 89 | MP0000685_abnormal_immune_system | 0.98440027 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.96352157 |
| 91 | MP0002184_abnormal_innervation | 0.94872979 |
| 92 | MP0008961_abnormal_basal_metabolism | 0.94346378 |
| 93 | MP0000955_abnormal_spinal_cord | 0.93389685 |
| 94 | MP0001963_abnormal_hearing_physiology | 0.93261478 |
| 95 | MP0005377_hearing/vestibular/ear_phenot | 0.92813117 |
| 96 | MP0003878_abnormal_ear_physiology | 0.92813117 |
| 97 | MP0002882_abnormal_neuron_morphology | 0.92579587 |
| 98 | MP0002419_abnormal_innate_immunity | 0.91099226 |
| 99 | MP0002723_abnormal_immune_serum | 0.90850578 |
| 100 | MP0002420_abnormal_adaptive_immunity | 0.89398842 |
| 101 | MP0004043_abnormal_pH_regulation | 0.87167732 |
| 102 | MP0004142_abnormal_muscle_tone | 0.86905606 |
| 103 | MP0001819_abnormal_immune_cell | 0.86801412 |
| 104 | MP0001188_hyperpigmentation | 0.86648848 |
| 105 | MP0002069_abnormal_eating/drinking_beha | 0.86353434 |
| 106 | MP0002638_abnormal_pupillary_reflex | 0.84835191 |
| 107 | MP0001177_atelectasis | 0.84494195 |
| 108 | MP0005025_abnormal_response_to | 0.83980293 |
| 109 | MP0000778_abnormal_nervous_system | 0.83537534 |
| 110 | MP0003866_abnormal_defecation | 0.82863059 |
| 111 | MP0008877_abnormal_DNA_methylation | 0.79832670 |
| 112 | MP0003195_calcinosis | 0.78366178 |
| 113 | MP0002452_abnormal_antigen_presenting | 0.78183125 |
| 114 | MP0006276_abnormal_autonomic_nervous | 0.77372543 |
| 115 | MP0009278_abnormal_bone_marrow | 0.77288009 |
| 116 | MP0000609_abnormal_liver_physiology | 0.76511751 |
| 117 | MP0009764_decreased_sensitivity_to | 0.75077966 |
| 118 | MP0003122_maternal_imprinting | 0.74926450 |
| 119 | MP0004130_abnormal_muscle_cell | 0.72712377 |
| 120 | MP0002928_abnormal_bile_duct | 0.72300082 |
| 121 | MP0001764_abnormal_homeostasis | 0.71925215 |
| 122 | MP0003634_abnormal_glial_cell | 0.71178692 |
| 123 | MP0003763_abnormal_thymus_physiology | 0.70679200 |
| 124 | MP0000920_abnormal_myelination | 0.67647551 |
| 125 | MP0005448_abnormal_energy_balance | 0.66620986 |
| 126 | MP0003632_abnormal_nervous_system | 0.66034444 |
| 127 | MP0003787_abnormal_imprinting | 0.64553255 |
| 128 | MP0005310_abnormal_salivary_gland | 0.64487946 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.60459406 |
| 130 | MP0010386_abnormal_urinary_bladder | 0.60095020 |
| 131 | MP0005464_abnormal_platelet_physiology | 0.57858359 |
| 132 | MP0005645_abnormal_hypothalamus_physiol | 0.57361902 |
| 133 | MP0001905_abnormal_dopamine_level | 0.55054255 |
| 134 | MP0004883_abnormal_blood_vessel | 0.55000624 |
| 135 | MP0005253_abnormal_eye_physiology | 0.54816356 |
| 136 | MP0002152_abnormal_brain_morphology | 0.53274738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.57919820 |
| 2 | Myokymia (HP:0002411) | 6.07959075 |
| 3 | Focal seizures (HP:0007359) | 4.76260810 |
| 4 | Visual hallucinations (HP:0002367) | 4.02252674 |
| 5 | Epileptic encephalopathy (HP:0200134) | 3.89489190 |
| 6 | Febrile seizures (HP:0002373) | 3.88144868 |
| 7 | Deep venous thrombosis (HP:0002625) | 3.86435791 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 3.56115890 |
| 9 | Absence seizures (HP:0002121) | 3.52616164 |
| 10 | Action tremor (HP:0002345) | 3.51057246 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.50404976 |
| 12 | Complement deficiency (HP:0004431) | 3.40574512 |
| 13 | Hyperventilation (HP:0002883) | 3.38322350 |
| 14 | Obstructive sleep apnea (HP:0002870) | 3.33747841 |
| 15 | Status epilepticus (HP:0002133) | 3.27424839 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 3.26452484 |
| 17 | Dialeptic seizures (HP:0011146) | 3.18766271 |
| 18 | Atonic seizures (HP:0010819) | 3.13540997 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 3.13417587 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.11922723 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.09117733 |
| 22 | Abnormality of the lower motor neuron (HP:0002366) | 3.01754144 |
| 23 | Postural instability (HP:0002172) | 2.98669049 |
| 24 | Hypobetalipoproteinemia (HP:0003563) | 2.98550908 |
| 25 | Gaze-evoked nystagmus (HP:0000640) | 2.98454287 |
| 26 | Xanthomatosis (HP:0000991) | 2.96906113 |
| 27 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.94837127 |
| 28 | Supranuclear gaze palsy (HP:0000605) | 2.94583914 |
| 29 | Poor eye contact (HP:0000817) | 2.92276677 |
| 30 | Abnormal social behavior (HP:0012433) | 2.91595209 |
| 31 | Impaired social interactions (HP:0000735) | 2.91595209 |
| 32 | Annular pancreas (HP:0001734) | 2.90512067 |
| 33 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.83539686 |
| 34 | Torticollis (HP:0000473) | 2.70465840 |
| 35 | Dysmetria (HP:0001310) | 2.69075587 |
| 36 | Depression (HP:0000716) | 2.68623144 |
| 37 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.64376817 |
| 38 | Hyperlipoproteinemia (HP:0010980) | 2.61055964 |
| 39 | Epidermoid cyst (HP:0200040) | 2.59247909 |
| 40 | Mutism (HP:0002300) | 2.56215673 |
| 41 | Focal dystonia (HP:0004373) | 2.51738877 |
| 42 | Myositis (HP:0100614) | 2.48572313 |
| 43 | Amyloidosis (HP:0011034) | 2.47743262 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.46239619 |
| 45 | Neurofibrillary tangles (HP:0002185) | 2.45549253 |
| 46 | Eczematoid dermatitis (HP:0000976) | 2.45109518 |
| 47 | Genetic anticipation (HP:0003743) | 2.44828043 |
| 48 | Abnormality of complement system (HP:0005339) | 2.44058222 |
| 49 | Optic neuritis (HP:0100653) | 2.42628883 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.42628883 |
| 51 | Intention tremor (HP:0002080) | 2.41943554 |
| 52 | Anxiety (HP:0000739) | 2.40646251 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 2.40202826 |
| 54 | Congenital stationary night blindness (HP:0007642) | 2.40055853 |
| 55 | Hemiparesis (HP:0001269) | 2.38831345 |
| 56 | Dysmetric saccades (HP:0000641) | 2.38281746 |
| 57 | Broad-based gait (HP:0002136) | 2.36851327 |
| 58 | Absent speech (HP:0001344) | 2.36463678 |
| 59 | Impaired smooth pursuit (HP:0007772) | 2.33574307 |
| 60 | Joint hemorrhage (HP:0005261) | 2.33102520 |
| 61 | Impaired vibratory sensation (HP:0002495) | 2.32987071 |
| 62 | Generalized myoclonic seizures (HP:0002123) | 2.32709759 |
| 63 | Abnormal eating behavior (HP:0100738) | 2.30284011 |
| 64 | Limb dystonia (HP:0002451) | 2.29480601 |
| 65 | Central scotoma (HP:0000603) | 2.29289496 |
| 66 | Craniofacial dystonia (HP:0012179) | 2.27746106 |
| 67 | Orchitis (HP:0100796) | 2.27255409 |
| 68 | Scanning speech (HP:0002168) | 2.25623346 |
| 69 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.25286529 |
| 70 | Stomatitis (HP:0010280) | 2.22677674 |
| 71 | Papilledema (HP:0001085) | 2.21737520 |
| 72 | Epileptiform EEG discharges (HP:0011182) | 2.20840076 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19579387 |
| 74 | Truncal ataxia (HP:0002078) | 2.19397813 |
| 75 | Sleep apnea (HP:0010535) | 2.19243395 |
| 76 | Protruding tongue (HP:0010808) | 2.19093810 |
| 77 | Drooling (HP:0002307) | 2.18218599 |
| 78 | Excessive salivation (HP:0003781) | 2.18218599 |
| 79 | Amblyopia (HP:0000646) | 2.15731786 |
| 80 | Recurrent bacterial skin infections (HP:0005406) | 2.15079594 |
| 81 | Stereotypic behavior (HP:0000733) | 2.14968002 |
| 82 | Fair hair (HP:0002286) | 2.12424058 |
| 83 | Bradykinesia (HP:0002067) | 2.12027410 |
| 84 | Conjugated hyperbilirubinemia (HP:0002908) | 2.11470359 |
| 85 | Sensorimotor neuropathy (HP:0007141) | 2.10339384 |
| 86 | Abnormality of the periventricular white matter (HP:0002518) | 2.09660991 |
| 87 | Memory impairment (HP:0002354) | 2.09437972 |
| 88 | Hemiplegia (HP:0002301) | 2.09305588 |
| 89 | Abnormality of the common coagulation pathway (HP:0010990) | 2.08304358 |
| 90 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.08105820 |
| 91 | Hypolipoproteinemia (HP:0010981) | 2.08070258 |
| 92 | Glomerulonephritis (HP:0000099) | 2.07860728 |
| 93 | EEG with generalized epileptiform discharges (HP:0011198) | 2.07449268 |
| 94 | Polyphagia (HP:0002591) | 2.04889184 |
| 95 | Hypercholesterolemia (HP:0003124) | 2.03996852 |
| 96 | Agitation (HP:0000713) | 2.03528617 |
| 97 | Spastic tetraparesis (HP:0001285) | 2.02577692 |
| 98 | Vertigo (HP:0002321) | 1.98793059 |
| 99 | Fat malabsorption (HP:0002630) | 1.98758910 |
| 100 | Recurrent abscess formation (HP:0002722) | 1.97184419 |
| 101 | Diplopia (HP:0000651) | 1.96590839 |
| 102 | Abnormality of binocular vision (HP:0011514) | 1.96590839 |
| 103 | Ankle clonus (HP:0011448) | 1.96436654 |
| 104 | Ventricular fibrillation (HP:0001663) | 1.96353015 |
| 105 | Generalized hypopigmentation of hair (HP:0011358) | 1.93872639 |
| 106 | Abnormality of saccadic eye movements (HP:0000570) | 1.93062981 |
| 107 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93009971 |
| 108 | Hypsarrhythmia (HP:0002521) | 1.92805759 |
| 109 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92782237 |
| 110 | Increased IgE level (HP:0003212) | 1.92572377 |
| 111 | Meningitis (HP:0001287) | 1.92152078 |
| 112 | Inappropriate behavior (HP:0000719) | 1.91931942 |
| 113 | Abnormality of the Achilles tendon (HP:0005109) | 1.91527981 |
| 114 | Acanthocytosis (HP:0001927) | 1.90818710 |
| 115 | Urinary urgency (HP:0000012) | 1.90576029 |
| 116 | Spontaneous abortion (HP:0005268) | 1.90255793 |
| 117 | Cholecystitis (HP:0001082) | 1.90247532 |
| 118 | Abnormal gallbladder physiology (HP:0012438) | 1.90247532 |
| 119 | Spastic gait (HP:0002064) | 1.89984121 |
| 120 | Pigmentary retinal degeneration (HP:0001146) | 1.89826125 |
| 121 | Lower limb muscle weakness (HP:0007340) | 1.89479654 |
| 122 | Blue irides (HP:0000635) | 1.89417612 |
| 123 | Slow saccadic eye movements (HP:0000514) | 1.87612275 |
| 124 | Absent/shortened dynein arms (HP:0200106) | 1.87553165 |
| 125 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.87553165 |
| 126 | Global brain atrophy (HP:0002283) | 1.87045509 |
| 127 | Neuronal loss in central nervous system (HP:0002529) | 1.86422063 |
| 128 | Rigidity (HP:0002063) | 1.84832022 |
| 129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84115747 |
| 130 | Recurrent fungal infections (HP:0002841) | 1.83980196 |
| 131 | Neonatal onset (HP:0003623) | 1.83955348 |
| 132 | Clonus (HP:0002169) | 1.83835379 |
| 133 | Lower limb hyperreflexia (HP:0002395) | 1.83325566 |
| 134 | Tetraplegia (HP:0002445) | 1.82203509 |
| 135 | Encephalitis (HP:0002383) | 1.77142490 |
| 136 | Akinesia (HP:0002304) | 1.76927088 |
| 137 | Abnormality of the fingertips (HP:0001211) | 1.76724103 |
| 138 | Widely spaced teeth (HP:0000687) | 1.76167716 |
| 139 | Stomach cancer (HP:0012126) | 1.75778015 |
| 140 | Apathy (HP:0000741) | 1.75722269 |
| 141 | Abnormality of the corticospinal tract (HP:0002492) | 1.75498532 |
| 142 | Inability to walk (HP:0002540) | 1.75173264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.02223640 |
| 2 | NTRK3 | 4.13992491 |
| 3 | MAP3K9 | 3.60334536 |
| 4 | RIPK4 | 3.23055798 |
| 5 | DAPK2 | 2.89909473 |
| 6 | MAP3K4 | 2.52291976 |
| 7 | KSR2 | 2.36632172 |
| 8 | MINK1 | 2.34055847 |
| 9 | MAP2K4 | 2.24962917 |
| 10 | MAP3K13 | 2.09047913 |
| 11 | PAK6 | 2.08141239 |
| 12 | MAP2K7 | 2.06254986 |
| 13 | MAP3K12 | 2.01167084 |
| 14 | SIK2 | 1.76296572 |
| 15 | FES | 1.70325490 |
| 16 | DAPK1 | 1.70321710 |
| 17 | MARK1 | 1.70238789 |
| 18 | MAP4K1 | 1.66049369 |
| 19 | STK38 | 1.63677443 |
| 20 | NTRK1 | 1.54092961 |
| 21 | PRKD3 | 1.50587836 |
| 22 | INSRR | 1.47802516 |
| 23 | KSR1 | 1.46694346 |
| 24 | NTRK2 | 1.41219139 |
| 25 | CDK5 | 1.39165132 |
| 26 | * CAMKK1 | 1.38073351 |
| 27 | MAP3K2 | 1.28690762 |
| 28 | PRPF4B | 1.23683481 |
| 29 | BMPR2 | 1.19546543 |
| 30 | ARAF | 1.15499468 |
| 31 | PRKCG | 1.13383746 |
| 32 | SGK3 | 1.09992620 |
| 33 | GRK5 | 1.08858129 |
| 34 | SGK2 | 1.08597268 |
| 35 | PDK1 | 1.07638045 |
| 36 | TAOK1 | 1.05065211 |
| 37 | BLK | 1.03263311 |
| 38 | MAP3K11 | 0.96492978 |
| 39 | PRKCH | 0.94102072 |
| 40 | CAMKK2 | 0.93251108 |
| 41 | RAF1 | 0.92814253 |
| 42 | PLK2 | 0.92697490 |
| 43 | TNK2 | 0.91016991 |
| 44 | LMTK2 | 0.90624667 |
| 45 | CAMK1 | 0.90406558 |
| 46 | MAP3K7 | 0.90014150 |
| 47 | CAMK1G | 0.89531311 |
| 48 | RIPK1 | 0.88133015 |
| 49 | PDPK1 | 0.87534342 |
| 50 | CAMK2A | 0.87188541 |
| 51 | STK11 | 0.86985310 |
| 52 | SGK494 | 0.86228460 |
| 53 | SGK223 | 0.86228460 |
| 54 | CASK | 0.85721106 |
| 55 | RET | 0.84688302 |
| 56 | WNK1 | 0.83878020 |
| 57 | ACVR1B | 0.83763256 |
| 58 | TAOK3 | 0.78429402 |
| 59 | SGK1 | 0.78352948 |
| 60 | MAP2K6 | 0.75932076 |
| 61 | MAP3K1 | 0.75601985 |
| 62 | PINK1 | 0.75549437 |
| 63 | PRKCZ | 0.74821026 |
| 64 | OXSR1 | 0.73226499 |
| 65 | PTK2B | 0.72770150 |
| 66 | CSK | 0.71941867 |
| 67 | TXK | 0.70443741 |
| 68 | MAPK13 | 0.67104732 |
| 69 | CAMK4 | 0.66814394 |
| 70 | JAK1 | 0.66221632 |
| 71 | TYK2 | 0.64731318 |
| 72 | SIK3 | 0.64455864 |
| 73 | IRAK4 | 0.64451993 |
| 74 | BTK | 0.64356577 |
| 75 | FGR | 0.63783389 |
| 76 | CDK19 | 0.62568992 |
| 77 | TNIK | 0.61855185 |
| 78 | GRK6 | 0.61744897 |
| 79 | TYRO3 | 0.61003482 |
| 80 | MAP3K14 | 0.60344439 |
| 81 | CAMK2B | 0.58957417 |
| 82 | MAPK12 | 0.58239954 |
| 83 | JAK2 | 0.57295974 |
| 84 | MAP3K6 | 0.56426119 |
| 85 | ITK | 0.55813013 |
| 86 | PRKCQ | 0.55672272 |
| 87 | CSNK1G2 | 0.54328260 |
| 88 | HIPK2 | 0.54209856 |
| 89 | FYN | 0.53283137 |
| 90 | SYK | 0.53026815 |
| 91 | IRAK2 | 0.52639549 |
| 92 | FRK | 0.51286997 |
| 93 | NEK6 | 0.50741440 |
| 94 | CSF1R | 0.50493088 |
| 95 | * RPS6KA3 | 0.50473976 |
| 96 | DYRK1A | 0.49811328 |
| 97 | CDK18 | 0.49501845 |
| 98 | PNCK | 0.48524304 |
| 99 | CDK15 | 0.48494688 |
| 100 | LYN | 0.48263956 |
| 101 | PKN1 | 0.48118951 |
| 102 | KIT | 0.47950807 |
| 103 | MAP2K1 | 0.47447388 |
| 104 | ALK | 0.47303894 |
| 105 | LCK | 0.47000250 |
| 106 | ZAP70 | 0.45143604 |
| 107 | PRKD2 | 0.45011655 |
| 108 | SIK1 | 0.44665527 |
| 109 | IKBKE | 0.44324128 |
| 110 | UHMK1 | 0.43736763 |
| 111 | PAK3 | 0.42937362 |
| 112 | GRK1 | 0.42561156 |
| 113 | MAPK7 | 0.41828873 |
| 114 | CDK14 | 0.40591487 |
| 115 | HCK | 0.39261855 |
| 116 | LATS2 | 0.38557123 |
| 117 | CDK11A | 0.37850793 |
| 118 | PRKACG | 0.37742145 |
| 119 | ADRBK1 | 0.37582871 |
| 120 | MAPK10 | 0.37486944 |
| 121 | CAMK2G | 0.36652025 |
| 122 | PRKCA | 0.36489810 |
| 123 | PRKCB | 0.36347231 |
| 124 | CAMK1D | 0.36032495 |
| 125 | AKT3 | 0.35657844 |
| 126 | MAP3K5 | 0.35196548 |
| 127 | MARK2 | 0.33292344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.92203070 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.55392659 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47154596 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.43591535 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.30917334 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.30372770 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.17922575 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.05542406 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 1.96120163 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.95232876 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.94347561 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.84975797 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.83306925 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 1.75078698 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.72359934 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.63544002 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.54636329 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52205805 |
| 19 | Phototransduction_Homo sapiens_hsa04744 | 1.52037164 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.48448259 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.47185730 |
| 22 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.42276743 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.39617510 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.39157333 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.36761405 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.33653775 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33610676 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.29273194 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25049877 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.22487083 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19212002 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16173556 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.11755805 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11273457 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10979995 |
| 36 | Allograft rejection_Homo sapiens_hsa05330 | 1.10903275 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.10591527 |
| 38 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.09374229 |
| 39 | Cocaine addiction_Homo sapiens_hsa05030 | 1.07061756 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.06962597 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.06188318 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 1.05655224 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04062599 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03982937 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02631946 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.01290845 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.00433586 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99689551 |
| 49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.98542921 |
| 50 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.97878764 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96548990 |
| 52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95235210 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94448901 |
| 54 | Asthma_Homo sapiens_hsa05310 | 0.93565607 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.90770311 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90672095 |
| 57 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.89707736 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.89128629 |
| 59 | Taste transduction_Homo sapiens_hsa04742 | 0.87472275 |
| 60 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85113151 |
| 61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84817968 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.83452589 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81385861 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79684852 |
| 65 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78245439 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77286087 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76122638 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72958561 |
| 69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72887366 |
| 70 | Platelet activation_Homo sapiens_hsa04611 | 0.72285782 |
| 71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71929081 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70092045 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68825415 |
| 74 | Gap junction_Homo sapiens_hsa04540 | 0.68589958 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67575687 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.67075298 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66755698 |
| 78 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66494021 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65946170 |
| 80 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65831777 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65635217 |
| 82 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64609923 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.64290541 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64048298 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63114314 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61918514 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61606780 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.58411775 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57753835 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.56570695 |
| 91 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55172095 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55068744 |
| 93 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54774463 |
| 94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54536273 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54193312 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53568157 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52015176 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51828591 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50957717 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50428287 |
| 101 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49781477 |
| 102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49724443 |
| 103 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49368291 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48701895 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48417362 |
| 106 | Phagosome_Homo sapiens_hsa04145 | 0.48296908 |
| 107 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47157746 |
| 108 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47108488 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46756873 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46482710 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46453822 |
| 112 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44662154 |
| 113 | Melanogenesis_Homo sapiens_hsa04916 | 0.44357796 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44336455 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44105999 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43330809 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43072746 |
| 118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42280714 |
| 119 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42175695 |
| 120 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.41993422 |
| 121 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41971341 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41790054 |
| 123 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41440243 |
| 124 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41194601 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.39301708 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.37798214 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36909079 |
| 128 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36871846 |
| 129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36588847 |
| 130 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.36541305 |
| 131 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.36239711 |
| 132 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36108549 |
| 133 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34541733 |
| 134 | Axon guidance_Homo sapiens_hsa04360 | 0.33510422 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33115704 |
| 136 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33002546 |

